This February, LML was pleased to host Professor Justyna Ożegalska-Trybalska, Deputy Director of the WIPO Joint Master’s Programme in Intellectual Property and New Technologies and Chair of Intellectual Property at Jagellonian University in Krakow, Poland. During her visit, Prof. Ożegalska-Trybalska explored the UK’s regulatory and legislative frameworks for personalised medicines in comparison with those of the European Union. In particular, Professor Ożegalska-Trybalska examined how the UK applies the ‘hospital exemption’, which allows certain treatments (includeing advanced gene therapies) to be used without full medicines approval. This research forms part of the REMEDIUM project, which seeks to rethink legal and regulatory approaches and identify best practices for ensuring the production of high-quality, safe, and effective medicines for patients across the EU.
In addition to advancing her research, Prof. Ożegalska-Trybalska took part in many meetings with members of the LML community, including Prof. Kathy Liddell (Director), Prof. Jeff Skopek (Deputy Director), and Prof. Mateo Aboy.
We are grateful to Prof Ożegalska-Trybalska for her engagement during her stay and look forward to future collaboration.